My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Sanofi - American Depositary Shares (NQ:SNY)

51.78 -0.36 (-0.69%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sanofi - American Depositary Shares

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

39 40 Next >

Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics ↗

January 09, 2023

Via Benzinga

What This Drug News Could Mean for Sanofi Shareholders ↗

January 08, 2023

This star drug for Sanofi is one step closer to approval in the European Union for another chronic inflammatory disease.

Via The Motley Fool

5 Top Pharma Stocks of 2022 to Buy for the Long Haul ↗

January 06, 2023

The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

Via InvestorPlace

What Does Sanofi's Debt Look Like? ↗

January 06, 2023

Over the past three months, shares of Sanofi Inc. (NASDAQ:SNY) increased by 20.92%. Before having a look at the importance of debt, let's look at how much debt Sanofi has.

Via Benzinga

FDA Permits Pharmacies To Distribute Abortion Pills, Tesla's Aggressive Discounting May Have Hit Gross Margins, Goldman Sachs Bullish On M&A Activity In Late 2023: Top Stories Today ↗

January 04, 2023

Reuters Goldman Sachs Bullish On M&A Deals Activity Picking Up In Late 2023

Via Benzinga

Sanofi Forecasts Foreign Exchange, Record Flu Vaccine Sales To Boost Q4 Earnings ↗

January 04, 2023

Via Benzinga

Could This Drug News Give a Lift to Eli Lilly Stock? ↗

January 01, 2023

In November, Eli Lilly received positive news from the U.S. Food and Drug Administration.

Via The Motley Fool

3 Medical Dividend Stocks That Hit the Sweet Spot ↗

December 26, 2022

These three offer high dividend yields and consistent revenue growth.

Via The Motley Fool

After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional Programs ↗

December 19, 2022

Via Benzinga

Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology

December 19, 2022

From Innate Pharma SA

Via Business Wire

Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review ↗

December 16, 2022

Moderna spiked on a cancer vaccine while Tesla continued to dive.

Via Investor's Business Daily

2 Best Biotech Stocks to Buy Right Now ↗

December 16, 2022

Demand for medicines and vaccines has nowhere to go but up over the long run.

Via The Motley Fool

Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis ↗

December 15, 2022

Via Benzinga

These Biotech Stocks Are the Nasdaq's Big Wednesday Winners ↗

December 14, 2022

Business wins are shining the spotlight on these two companies.

Via The Motley Fool

Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today? ↗

December 14, 2022

KYMR stock traders are bidding up the share price today as Kymera Therapeutics teams up to take a skin condition treatment to the next phase.

Via InvestorPlace

Kymera Therapeutics Stock Jumps After Positive Data From Atopic Dermatitis Trial ↗

December 14, 2022

Via Benzinga

Why Small Biotech Kymera Just Snagged Sanofi's Interest And Surged 28% ↗

December 14, 2022

The company is working on protein degradation in cancer and inflammatory diseases.

Via Investor's Business Daily

Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal ↗

December 12, 2022

HZNP stock is up on news that Horizon Therapeutics is being bought by Amgen in a friendly deal that's positive for both companies.

Via InvestorPlace

Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion Deal ↗

December 12, 2022

The deal comes a day after Sanofi dropped out of the bidding process.

Via Investor's Business Daily

Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12 ↗

December 12, 2022

Reuters Broadcom's Vmware Draws More Regulatory Attention, This Time From EU

Via Benzinga

Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share ↗

December 12, 2022

Via Benzinga

Will This Potential Approval Be a Winner for Sanofi's Shareholders? ↗

December 09, 2022

Sanofi and Regeneron's Dupixent moved closer to regulatory approval to treat another skin disease in the European Union.

Via The Motley Fool

Can Pfizer, Johnson & Johnson Continue Outperforming the Index?

December 09, 2022

Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.

Via MarketBeat

France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine ↗

December 08, 2022

Via Benzinga

This Monster Dividend Stock Isn't Done Growing ↗

December 08, 2022

Is another deal on the way for Johnson & Johnson?

Via The Motley Fool

Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration ↗

December 08, 2022

Via Benzinga

Fusion Fuel (HTOO) Stock Is Up 11% on HUGE Deal News ↗

December 07, 2022

Fusion Fuel (HTOO) stock is heading higher on Wednesday after the company secured a deal with the Portuguese government.

Via InvestorPlace

Why Is TransCode Therapeutics (RNAZ) Stock Up 148% Today? ↗

December 07, 2022

TransCode Therapeutics (RNAZ) stock is rallying higher on Wednesday after the company withdrew plans for a secondary offering.

Via InvestorPlace

SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers ↗

December 07, 2022

Sanofi (SNY) stock is in the news as one analyst believes the latest court ruling is the "best-case scenario" for the drugmaker.

Via InvestorPlace

Meta Criticized For Providing Extra Protection To Certain Users, Twitter HQ Bedrooms Under Regulatory Scrutiny, Juul Settles Over 5,000 Lawsuits: Top Stories Wednesday, Dec. 07 ↗

December 07, 2022

Benzinga

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.